Preface: Guidelines for the Treatment of Travelers' Diarrhea in Deployed Military Personnel

Mil Med. 2017 Sep;182(S2):1-3. doi: 10.7205/MILMED-D-17-00066.

Abstract

Diarrheal disease frequently affects military personnel deployed to developing countries, resulting in decreased job performance and potential negative impacts on military operational readiness. Travelers' diarrhea is a self-limiting illness; however, antibiotic treatment (with and without use of adjunct loperamide therapy) has been shown to significantly reduce clinical presentation of symptoms and duration of illness. Nonetheless, the choice of first-line antibiotics must be carefully considered as increasing resistance of enteric pathogens in endemic regions has rendered many first-line antibiotics ineffective (e.g., Campylobacter spp. are resistant to fluoroquinolones in Southeast Asia). Presently, there are no standardized recommendations for the treatment of travelers' diarrhea among deployed military personnel. Therefore, an expert panel was convened to develop evidence-based, consensus-driven guidelines that address key clinical issues related to self-treatment, antibiotic treatment for acute watery diarrhea and febrile diarrhea/dysentery, and diagnostics. These guidelines "Management of Acute Diarrheal Illness during Deployment" are published in this supplement along with articles reviewing the evidence-based data that supported their development.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antidiarrheals / therapeutic use
  • Diarrhea / therapy*
  • Guidelines as Topic*
  • Humans
  • Loperamide / therapeutic use
  • Military Personnel / statistics & numerical data*
  • Travel / statistics & numerical data*

Substances

  • Anti-Bacterial Agents
  • Antidiarrheals
  • Loperamide